- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 207/36 - Oxygen or sulfur atoms
Patent holdings for IPC class C07D 207/36
Total number of patents in this class: 191
10-year publication summary
|
8
|
21
|
10
|
16
|
15
|
15
|
10
|
13
|
12
|
7
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Takeda Pharmaceutical Company Limited | 2699 |
13 |
| Daewoong Pharmaceutical Co., Ltd. | 368 |
8 |
| Novartis AG | 10175 |
7 |
| Syngenta Participations AG | 1492 |
5 |
| Omeros Corporation | 306 |
5 |
| Cv6 Therapeutics (NI) Limited | 33 |
5 |
| Bayer Cropscience AG | 1836 |
4 |
| Ottawa Hospital Research Institute | 113 |
4 |
| University of Leicester | 217 |
4 |
| Infex Therapeutics Limited | 20 |
4 |
| Vectus Biosystems Limited | 28 |
3 |
| Sanofi | 4322 |
3 |
| Ascentage Pharma (Suzhou) Co., Ltd. | 230 |
3 |
| Ascentage Pharma Group Corp Limited | 151 |
3 |
| Rewind Therapeutics NV | 6 |
3 |
| Tay Therapeutics Limited | 17 |
3 |
| Bayer Intellectual Property GmbH | 2356 |
2 |
| Abbvie Inc. | 1799 |
2 |
| Alere San Diego, Inc. | 62 |
2 |
| The Brigham and Women's Hospital, Inc. | 2299 |
2 |
| Other owners | 106 |